Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HSPB2 facilitates neural regeneration through autophagy for sensorimotor recovery after traumatic brain injury
Yichen Huang, Shan Meng, Biwu Wu, Hong Shi, Yana Wang, Jiakun Xiang, Jiaying Li, Ziyu Shi, Gang Wu, Yanchen Lyu, Xu Jia, Jin Hu, Zhi-Xiang Xu, Yanqin Gao
Yichen Huang, Shan Meng, Biwu Wu, Hong Shi, Yana Wang, Jiakun Xiang, Jiaying Li, Ziyu Shi, Gang Wu, Yanchen Lyu, Xu Jia, Jin Hu, Zhi-Xiang Xu, Yanqin Gao
View: Text | PDF
Research Article Neuroscience

HSPB2 facilitates neural regeneration through autophagy for sensorimotor recovery after traumatic brain injury

  • Text
  • PDF
Abstract

Autophagy is a promising target for promoting neural regeneration, which is essential for sensorimotor recovery following traumatic brain injury (TBI). Whether neuronal heat shock protein B2 (HSPB2), a small molecular heat shock protein, reduces injury and promotes recovery following TBI remains unclear. In this study, we demonstrated that HSPB2 was significantly increased in the neurons of a TBI mouse model, patients, and primary neuron cultures subjected to oxygen/glucose deprivation and reperfusion treatment. Upon creating a tamoxifen-induced neuron-specific HSPB2 overexpression transgenic mouse model, we found that elevated HSPB2 levels promoted long-term sensorimotor recovery and alleviated tissue loss after TBI. We also demonstrated that HSPB2 enhanced white matter structural and functional integrity, promoted central nervous system (CNS) plasticity, and accelerated long-term neural remodeling. Moreover, we found that autophagy occurred around injured brain tissues in patients, and the pro-regenerative effects of HSPB2 relied on its autophagy-promoting function. Mechanistically, HSPB2 may regulate autophagy possibly by forming the HSPB2/BCL2-associated athanogene 3/sequestosome-1 complex to facilitate the clearance of erroneously accumulated proteins in the axons. Treatment with the autophagy inhibitor chloroquine during the acute stage or delayed induction of HSPB2 remarkably impeded HSPB2’s long-term reparative function, indicating the importance of acute-stage autophagy in long-term neuro-regeneration. Our findings highlight the beneficial role of HSPB2 in neuro-regeneration and functional recovery following acute CNS injury, thereby emphasizing the therapeutic potential of autophagy regulation for enhancing neuro-regeneration.

Authors

Yichen Huang, Shan Meng, Biwu Wu, Hong Shi, Yana Wang, Jiakun Xiang, Jiaying Li, Ziyu Shi, Gang Wu, Yanchen Lyu, Xu Jia, Jin Hu, Zhi-Xiang Xu, Yanqin Gao

×

Figure 13

HSPB2 promotes long-term neuro-recovery through acute-stage neuronal autophagy.

Options: View larger image (or click on image) Download as PowerPoint
HSPB2 promotes long-term neuro-recovery through acute-stage neuronal aut...
(A) Experimental design for autophagy inhibition. (B) Illustration and quantitative analysis of tissue loss volume at 35 days postinjury with CQ treatment. Dotted boxes indicate the loss area; scale bar = 3 mm; n = 5, analyzed using 1-way ANOVA and post hoc Bonferroni’s test. (C) Quantitative analysis of body curl, grid-walking test, and rotarod test from 3 to 35 days postinjury with CQ treatment. n = 15 WT-TBI, 10 WT-TBI+CQ, 17 TG-TBI, and 10 TG-TBI+CQ, analyzed using 2-way ANOVA and post hoc Bonferroni’s test. *TG versus WT, §CQ versus non-CQ, or as indicated. */§: P < 0.05, **/§§: P < 0.01, ***/§§§: P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts